SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-040786
Filing Date
2023-11-14
Accepted
2023-11-14 08:30:35
Documents
14
Period of Report
2023-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42792
2 ex99-1.htm EX-99.1 58649
3 ex99-1_001.jpg GRAPHIC 16200
  Complete submission text file 0001493152-23-040786.txt   311896

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE rnxt-20231114.xsd EX-101.SCH 3015
5 XBRL LABEL FILE rnxt-20231114_lab.xml EX-101.LAB 34916
6 XBRL PRESENTATION FILE rnxt-20231114_pre.xml EX-101.PRE 22789
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3568
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

IRS No.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40738 | Film No.: 231401761
SIC: 2834 Pharmaceutical Preparations